Literature DB >> 2141684

Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45).

T Mustelin1, A Altman.   

Abstract

pp56lck, encoded by the lck proto-oncogene, is a non-receptor tyrosine protein kinase (TPK) found in all T lymphocytes. A significant fraction of pp56lck is tightly associated with the cytoplasmic domains of CD4 and CD8 glycoproteins, suggesting an important role for it in thymic development and T cell activation. We have studied the regulation of the tyrosine kinase activity of pp56lck and found recently that it becomes rapidly activated in isolated T cell membranes by an endogenous mechanism apparently involving a phosphotyrosine phosphatase (PTPase). Moreover pp56lck was activated upon addition of isolated CD45 (leukocyte common antigen), a major membrane PTPase, and activation was absent in T cell mutants lacking CD45. Here, we address in more detail the mechanisms of pp56lck activation by the CD45 PTPase and show that this event is time-dependent, sensitive to Na3VO4 (which blocks the PTPase activity of CD45), and is accompanied by dephosphorylation of a regulatory tyrosine residue (Tyr-505) near the C-terminus of pp56lck. This provides a molecular mechanism for regulation of the catalytic activity of pp56lck by CD45, which thus is likely to be the physiological activator of pp56lck. Activation of pp56lck by the CD45 PTPase may underlie many of the reported immunomodulatory effects of antibodies to CD45, and provides further support for the notion that CD45-mediated tyrosine dephosphorylation plays a critical role in T cell activation and growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141684

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 3.  Consequences of a mutation in the UNC119 gene for T cell function in idiopathic CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

4.  Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues.

Authors:  B J Goldstein; W R Zhang; N Hashimoto; C R Kahn
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

5.  Cytokinetic failure and asynchronous nuclear division in BHK cells overexpressing a truncated protein-tyrosine-phosphatase.

Authors:  D E Cool; P R Andreassen; N K Tonks; E G Krebs; E H Fischer; R L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 7.  Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.

Authors:  Smaragda Lamprianou; Sheila Harroch
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 8.  The c-src family of protein-tyrosine kinases.

Authors:  P M Brickell
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

Review 9.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

10.  Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Authors:  Souad Rahmouni; Torkel Vang; Andres Alonso; Scott Williams; Marianne van Stipdonk; Chiara Soncini; Michel Moutschen; Stephen P Schoenberger; Tomas Mustelin
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.